• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素依赖型糖尿病与产前筛查结果:区域筛查项目的当前经验

Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.

作者信息

Crossley J A, Berry E, Aitken D A, Connor J M

机构信息

Duncan Guthrie Institute of Medical Genetics, Yorkhill, Glasgow, U.K.

出版信息

Prenat Diagn. 1996 Nov;16(11):1039-42. doi: 10.1002/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#.

DOI:10.1002/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#
PMID:8953638
Abstract

From around 91,000 women having routine prenatal screening for Down's syndrome and neural tube defects between July 1992 and October 1995, 261 women were identified as having insulin-dependent diabetes mellitus (IDDM). Alpha-fetoprotein (AFP) and human chorionic gonadotrophin (hCG) levels were reduced in these women, with median levels of 0.89 and 0.91 multiples of the median (MOM), respectively. The IDDM patients had a median weight which was 6 kg heavier than that of non-IDDM women. After correction for maternal weight, the AFP and hCG levels in the IDDM patients were 0.98 and 0.92 MOM, respectively. In routine practice, using results which were not weight-corrected, the IDDM women were neither over- nor under-represented in the high-risk group for Down's syndrome, but showed a tendency to be under-represented in the high-risk group for neural tube defects.

摘要

在1992年7月至1995年10月期间,对约91,000名进行唐氏综合征和神经管缺陷常规产前筛查的女性进行了研究,其中261名女性被确诊为胰岛素依赖型糖尿病(IDDM)。这些女性的甲胎蛋白(AFP)和人绒毛膜促性腺激素(hCG)水平降低,中位数水平分别为中位数倍数(MOM)的0.89和0.91。IDDM患者的中位数体重比非IDDM女性重6千克。校正孕妇体重后,IDDM患者的AFP和hCG水平分别为0.98 MOM和0.92 MOM。在常规实践中,使用未经体重校正的结果时,IDDM女性在唐氏综合征高危组中的比例既没有过高也没有过低,但在神经管缺陷高危组中的比例有偏低的趋势。

相似文献

1
Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.胰岛素依赖型糖尿病与产前筛查结果:区域筛查项目的当前经验
Prenat Diagn. 1996 Nov;16(11):1039-42. doi: 10.1002/(SICI)1097-0223(199611)16:11<1039::AID-PD985>3.0.CO;2-#.
2
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?染色体疾病和神经管缺陷(NTD)的生化筛查:在胰岛素依赖型糖尿病(IDDM)中,调整母体甲胎蛋白(AFP)水平是否仍然合适?
Prenat Diagn. 2001 May;21(5):383-6. doi: 10.1002/pd.72.
3
Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病女性孕中期唐氏综合征产前筛查标志物
Prenat Diagn. 2004 Oct;24(10):804-7. doi: 10.1002/pd.994.
4
Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.胰岛素依赖型糖尿病孕妇血清抑制素A水平:对唐氏综合征筛查的意义
Prenat Diagn. 1996 Oct;16(10):923-6. doi: 10.1002/(SICI)1097-0223(199610)16:10<923::AID-PD970>3.0.CO;2-A.
5
Serum markers for Down's syndrome in relation to number of previous births and maternal age.唐氏综合征血清标志物与既往分娩次数及母亲年龄的关系。
Prenat Diagn. 1996 Aug;16(8):699-703. doi: 10.1002/(SICI)1097-0223(199608)16:8<699::AID-PD919>3.0.CO;2-P.
6
Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者母体血清甲胎蛋白水平调整的影响
Am J Med Genet. 1998 Jan 13;75(2):176-8.
7
Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.胰岛素依赖型糖尿病孕妇血清中未结合雌三醇和人绒毛膜促性腺激素水平:对唐氏综合征筛查的意义。
Br J Obstet Gynaecol. 1992 Jan;99(1):51-3. doi: 10.1111/j.1471-0528.1992.tb14392.x.
8
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.解读产前筛查结果时孕产妇体重调整管理的优化
Prenat Diagn. 1996 Dec;16(12):1115-9. doi: 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6.
9
Triploidy identified through second-trimester serum screening.通过孕中期血清筛查发现的三倍体。
Prenat Diagn. 2005 Mar;25(3):229-33. doi: 10.1002/pd.1115.
10
Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.亚洲人结合血清游离β-人绒毛膜促性腺激素和甲胎蛋白与孕妇年龄进行唐氏综合征筛查策略的比较。
Prenat Diagn. 1997 Aug;17(8):707-16.

引用本文的文献

1
Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells into Insulin Producing Cells.脐带来源间充质干细胞向胰岛素分泌细胞的分化
Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):220-229.
2
First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.用于唐氏综合征筛查的孕早期和孕中期血清检测,以及有无孕早期超声检查的情况。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012599. doi: 10.1002/14651858.CD012599.
3
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
孕早期单独进行超声检查或与孕早期血清检查联合用于唐氏综合征筛查。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012600. doi: 10.1002/14651858.CD012600.
4
Urine tests for Down's syndrome screening.唐氏综合征筛查的尿液检测。
Cochrane Database Syst Rev. 2015 Dec 10;2015(12):CD011984. doi: 10.1002/14651858.CD011984.
5
First trimester serum tests for Down's syndrome screening.孕早期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD011975. doi: 10.1002/14651858.CD011975.
6
Second trimester serum tests for Down's Syndrome screening.孕中期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925.
7
Korean-specific parameter models for calculating the risk of Down syndrome in the second trimester of pregnancy.计算妊娠中期唐氏综合征风险的韩国特定参数模型。
J Korean Med Sci. 2011 Dec;26(12):1619-24. doi: 10.3346/jkms.2011.26.12.1619. Epub 2011 Nov 29.